The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

Diagnosis involves polysomnography, and treatment options include CPAP ... These are obstructive, central and mixed sleep apnea. Let’s see what each one is about. 1. Obstructive Sleep Apnea ...

Central Sleep Apnea (CSA): Occurs when the brain ... Management of sleep apnea Treatment of sleep apnea was revolutionized in the 1980’s by the invention of positive pressure devices (CPAP ...

Though past research has focused on the health benefits of cheese, the new data examined its direct relationship to the ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

Washington (AFP) – US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans.

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens new tab weight-loss ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

“A 10-year-old with uncontrolled central sleep apnea is about 200 ... and added that treatment of sleep apnea may improve epileptic seizures. The findings were presented on December 7 at the ...